Literature DB >> 25147082

Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.

Manish Tandon1, Zujian Chen, Jitesh Pratap.   

Abstract

Crosstalk among mitogen-activated protein kinase (MAPK) and phosphatidyl inositol 3' kinase (PI3K) signaling pathways integrates extracellular cues to regulate mammary epithelial cell growth, proliferation, differentiation, and survival. The runt-related transcription factor, Runx2, is expressed in normal mammary epithelium and promotes differentiation, however, its function in regulation of the MAPK and PI3K signaling crosstalk is not known. We determined the function of Runx2 expression in growth factor-mediated phosphorylation of Erk1/2 and Akt, key downstream kinases in MAPK and PI3K pathway crosstalk in MCF-10A mammary epithelial cells. The Runx2-mediated alterations in cell signaling and associated changes in phenotype were determined by real-time quantitative PCR, Western blotting, immunofluorescence, and flow cytometry approaches. The results revealed that ectopic Runx2 expression differentially downregulates the growth factor (EGF vs. IGF or insulin)-induced pErk1/2 and pAkt levels. Additionally, the ectopic Runx2 expression increases FOXO1 levels, cell cycle G1 stage and promotes survival of MCF-10A cells. Furthermore, we demonstrate that Runx2 expression increases EGF-induced phosphorylation of epidermal growth factor receptor (pEGFR) and relieves Mek/Erk-mediated negative regulation of pEGFR and pAkt levels. Altogether, our results identify functions of Runx2 in MAPK and PI3K signaling crosstalk in MCF-10A cells that could be critical in understanding the mammary epithelial cell growth and survival.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT; EGFR; ERK; MAPK; PI3K; RUNX2; SIGNALING CROSSTALK

Mesh:

Substances:

Year:  2014        PMID: 25147082     DOI: 10.1002/jcb.24939

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  Role of Runx2 in IGF-1Rβ/Akt- and AMPK/Erk-dependent growth, survival and sensitivity towards metformin in breast cancer bone metastasis.

Authors:  M Tandon; Z Chen; A H Othman; J Pratap
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

2.  RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.

Authors:  Filip Matthijssens; Nitesh D Sharma; Monique Nysus; Christian K Nickl; Huining Kang; Dominique R Perez; Beatrice Lintermans; Wouter Van Loocke; Juliette Roels; Sofie Peirs; Lisa Demoen; Tim Pieters; Lindy Reunes; Tim Lammens; Barbara De Moerloose; Filip Van Nieuwerburgh; Dieter L Deforce; Laurence C Cheung; Rishi S Kotecha; Martijn Dp Risseeuw; Serge Van Calenbergh; Takeshi Takarada; Yukio Yoneda; Frederik W van Delft; Richard B Lock; Seth D Merkley; Alexandre Chigaev; Larry A Sklar; Charles G Mullighan; Mignon L Loh; Stuart S Winter; Stephen P Hunger; Steven Goossens; Eliseo F Castillo; Wojciech Ornatowski; Pieter Van Vlierberghe; Ksenia Matlawska-Wasowska
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 3.  RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression.

Authors:  Karine A Cohen-Solal; Rajeev K Boregowda; Ahmed Lasfar
Journal:  Mol Cancer       Date:  2015-07-25       Impact factor: 27.401

4.  miR-218 overexpression suppresses tumorigenesis of papillary thyroid cancer via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2.

Authors:  Mingkun Han; Liwei Chen; Yang Wang
Journal:  Onco Targets Ther       Date:  2018-09-28       Impact factor: 4.147

5.  A Novel Role for miR-1305 in Regulation of Pluripotency-Differentiation Balance, Cell Cycle, and Apoptosis in Human Pluripotent Stem Cells.

Authors:  Shibo Jin; Joseph Collin; Lili Zhu; David Montaner; Lyle Armstrong; Irina Neganova; Majlinda Lako
Journal:  Stem Cells       Date:  2016-07-11       Impact factor: 6.277

6.  Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.

Authors:  Baoshan Hu; Xiangchao Meng; Yan Zhang; Mohammad Monir Hossain; Lijun Wu; Yuanyuan Zhang; Xiaobing Peng; Xuepeng Zhang
Journal:  Oncol Rep       Date:  2018-01-26       Impact factor: 3.906

Review 7.  Targeting the C-Terminal Domain Small Phosphatase 1.

Authors:  Harikrishna Reddy Rallabandi; Palanivel Ganesan; Young Jun Kim
Journal:  Life (Basel)       Date:  2020-05-08

8.  Ectopic expression of the osteogenic master gene RUNX2 in melanoma.

Authors:  Maria Teresa Valenti; Luca Dalle Carbonare; Monica Mottes
Journal:  World J Stem Cells       Date:  2018-07-26       Impact factor: 5.326

9.  RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS-mutant colorectal cancer.

Authors:  Tonći Šuštić; Evert Bosdriesz; Sake van Wageningen; Lodewyk F A Wessels; René Bernards
Journal:  Transl Oncol       Date:  2019-12-20       Impact factor: 4.243

Review 10.  Regulation of Cell Cycle Progression by Growth Factor-Induced Cell Signaling.

Authors:  Zhixiang Wang
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.